Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

ARNA 4.71 +0.10 (2.17%)
price chart
Stocks to Keep Your Eyes on-Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Las Vegas, NV - July 28, 2014 - (Tech Sonian) �Arena Pharmaceuticals, Inc. (ARNA) reported that its wholly owned subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement for BELVIQ� (lorcaserinHCl) with ...
Related articles »  
Laggards - Auxilium Pharmaceuticals, Inc. (AUXL), Arena Pharmaceuticals, Inc ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported that Eisai Inc. has completed its planned increase of more than 200 new contract sales representatives in its Metabolic Business Unit, increasing the sales force for BELVIQ� by 50% to approximately ...
Whats Hot Today : ServiceNow, Inc. (NYSE:NOW), Arena Pharmaceuticals, Inc ...
On JULY 25, ServiceNow Inc (NYSE:NOW) CFO Michael Scarpelli sold 10,000 shares of the stock on the open market in a transaction dated Tuesday, July 22nd.
Related articles »  
Active Watch List : Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Amazon.com ...
Arena Pharmaceuticals (NASDAQ:ARNA) CEO Jack Lief sold 223,525 shares of Arena Pharmaceuticals stock in a transaction dated Tuesday, July 1st.
Hot Stock List: Arena Pharmaceuticals (NASDAQ:ARNA), Glu Mobile (NASDAQ ...  Crazy Joys
Stocks in Focus: Delta Air Lines Inc. (NYSE:DAL), Arena Pharmaceuticals ...  WallStreet Scope
Related articles »  
Eisai and Arena Pharmaceuticals Announce BELVIQ(R) (lorcaserin HCl) CIV ...
WOODCLIFF LAKE, N.J. and SAN DIEGO, July 29, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that BELVIQ(R) (lorcaserin HCl) has been nominated by the Galien Foundation and Awards Committee ...
Related articles »  
Arena Pharmaceuticals Inc. Still Down After CEO's Sale
"Week-over-week prescriptions are increasing. We're very excited about that. And we expect those prescriptions to continue to increase as, yet a larger salesforce, goes into the field in the next few weeks.
Most Active Buzz: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Oi SA (NYSE ...
Lakeway, NY - (MARKET NEWS CALL) - 7/29/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Related articles »  
Traders Favorite: Galena Biopharma, Inc. (NASDAQ:GALE), Arena ...
... updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on Galena Biopharma, Inc. (NASDAQ:GALE), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Alexion Pharmaceuticals, Inc.(NASDAQ:ALXN).
Why Arena Pharmaceuticals (ARNA) Stock Is Dropping Today
NEW YORK (TheStreet) -- Arena Pharmaceuticals (ARNA_) shares are plummeting, down -8.1% to $5.37, on Monday after CEO Jack Lief sold 223,525 shares of the company at an average price $5.85 for a total transaction of $1,307,621.25, according to an ...
Arena chief's stock sale invites criticism (ARNA)  Seeking Alpha
Arena Stock Takes A Tumble � CEO Sells Shares, Investor Confidence Falls  Bidness Etc
Related articles »  
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Sells Marketing And Distribution ...
Dallas, Texas 07/22/2014 (ustradevoice) - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)'s wholly owned subsidiary Arena Pharmaceuticals GmbH has undertaken a marketing and supply deal for BELVIQ� with Abic Marketing Limited, the local Israel-based ...
Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ ...  Wall Street Journal
Teva's subsidiary, Abic to market Arena Pharma's Belviq in Israel  pharmabiz.com
Related articles »